CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Bayer Crop Science

Johnny Ivanyi, Supply Chain Director, Global Head of Distribution Excellence

Impact of Digital Transformation on Supply Chain

Johnny Ivanyi

Johnny Ivanyi

Johnny Ivanyi is currently working as the Global Head of Distribution Operations at Bayer Crop Science. He is responsible for leading the global distribution operational excellence strategy and transforming logistics across the regions by identifying, assessing, and implementing innovative, strategy methods and new technologies such as Global Transportation Management Solutions (TMS), Global Warehousing Management Solutions (WMS), Last Mile Visibility, and Logistics Smart Centers, including Business Intelligence and Data Analytics. Additionally, Ivanyi oversees digital transformation efforts that results in potential cost savings, distinct customer experiences, and a competitive edge while fostering strong stakeholder connections and creating external collaborations.


How has the supply chain space changed lately?


Even two years back, the domestic market was the only go-to option for a majority of customers. However, now buyers have gone global, making it mandatory for businesses to focus on swiftly transporting their products across the globe.


Within Bayer, we are focusing on improving the end-to-end supply chain visibility across air, water, and road transport to foster efficient international logistics operations. And to gain better traceability across the entire supply chain, we use tools like TMS Plus, which comes with a real-time progress mapping feature. Moreover, searching for better ports and carriers for efficient product handling and swift transport is also among our foremost concerns.


Could you walk us through some of your recent projects at Bayer?


Currently, we are focused on the digital transformation of our supply chain by implementing new systems. Also, we are expanding the reach of our transport management systems to 90 countries by working with our partner—Blue Yonder, a leading end-to-end supply chain management solution provider.


Such efforts will help us process transportation planning, execution, and payment within a single tool.


On the Supply chain visibility front, we are focused on outreaching our last-mile traceability to North America, APAC, and Latin America. Also, to bring transparency to our operations and avoid manual interventions, we are connecting Bayer’s ERP systems with POS providers.


What will be advice to industry peers?   


Along with investing billions of dollars in systems and process improvements during a digital transformation journey, businesses must also transform their people. At Bayer, we have logistic providers, also called our partners, whom we rigorously coach to make them more honest and responsible.


Within Bayer, we are focusing on improving the end-to-end supply chain visibility across air, water, and road transport to foster efficient international logistics operations

 


Change management is the second aspect, where using the right employee training, businesses must induce a digital mindset and rational decision-making skills. Moreover, hiring the right talent is a must to make the supply-chain operations robust. Finally, to best suit their operations across diverse geographical locations, companies also need to hire local talents so that the employees can address the different socio-cultural needs of different locations.


Bayer and Bayer Cross are registered trademarks of Bayer Group. ©2022 Bayer Group. All rights reserved.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/leadership-perspective/impact-of-digital-transformation-on-supply-chain-nwid-1174.html